Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed in low-risk gestational trophoblastic tumor
NCT00096187Phase 2Terminated
- Sponsor
- GOG Foundation
- Start
- Jul 2005
- Primary completion
- Jul 2007
- Countries
- 1
01
Overview
Phase 2, open-label trial of pemetrexed in gestational trophoblastic tumor (GTN), sponsored by GOG Foundation. Started Jul 2005; status: terminated.
02
Drugs
pemetrexed
03
Conditions
gestational trophoblastic tumor (GTN)
Beyond the preview
Go deeper on NCT00096187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00096187.